SEARCH

SEARCH BY CITATION

References

  • 1
    Miller AB. Conundrums in screening for cancer. Mini Review. Int J Cancer 2010;126:103946.
  • 2
    The Canadian Partnership Against Cancer. Cervical Cancer Screening in Canada Monitoring Program Performance 2006–2008. Toronto: The Canadian Partnership Against Cancer, 2011.
  • 3
    Department of Health and Ageing. National Cervical Screening Program. Canberra, Australia: Australian Government. [www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/cervical-about]. Accessed 14 April 2013.
  • 4
    Anttila A, Ronco G, Clifford G, Bray F, Hakama M, Arbyn M, et al. Cervical cancer screening programs and policies in 18 European Countries. Br J Cancer 2004;91:93541.
  • 5
    Miller AB. IARC Handbooks on Cancer Prevention. Cervix Cancer Screening, vol. 10. Lyon: IARC Press, 2005.
  • 6
    Canadian Task Force on Preventive Health Care. Recommendations on screening for cervical cancer. CMAJ 2013;185:3545.
  • 7
    Miller AB, Lindsay J, Hill GB. Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. Int J Cancer 1976;17:60212.
  • 8
    Task Force appointed by the Conference of Deputy Ministers of Health. Cervical cancer screening programmes. Can Med Assoc J 1976;114:100333.
  • 9
    Walton RJ, Allen HH, Anderson GH, Boyes DA, Blanchet M, Carmichael J, et al. Cervical cancer screening programmes: summary of the 1982 Canadian task force report. CMAJ 1982;127:5819.
  • 10
    Stuart GC, O'Connell G, Ferenczy A. Screening for cancer of the cervix. CMAJ 1991;145:1195.
  • 11
    Dickinson JA, Stankiewicz A, Popadiuk C, Pogany L, Onysko J, Miller AB. Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006. BMC Public Health 2012;12:992.
  • 12
    Sasieni P, Castanon A, Parkin MD. Response to: why young women should be screened for cervical cancer: the distinction between CIN2 and CIN3. Int J Cancer 2009;124:4614.
  • 13
    Chan PG, Sung HY, Sawaya G. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Oynecol 2003;1102:76573.
  • 14
    Sasieini P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population-based case-control study of prospectively recorded data. BMJ 2009;339:b2968.
  • 15
    Sasieni P, Adams J and Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:8893.
  • 16
    Popadiuk C, Stankiewicz A, Dickinson J, Pogany L, Miller AB, Onysko J. Invasive cervical cancer incidence and mortality among canadian women aged 15 to 29 and the impact of screening. J Obstet Gynaecol Can 2012;34:116776.
  • 17
    Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions:systematic review and meta-analysis. Lancet 2006;367:48998.
  • 18
    Society of Obstetricians and Gynaecologists of Canada, Society of Gynecological Oncology of Canada, Society of Canadian Colposcopists. Position statement: recommendations on screening for cervical cancer. 20 Feb 2013.[www.sogc.org/media/documents/medCervicalCancerScreeningENG130220.pdf]. Accessed 13 April 2013.
  • 19
    Murphy J, Elit L. Cervical screening guidelines – discordance discussed. CMAJ e-letter 22 March 2013 [www.cmaj.ca/content/185/1/35.full#responses].
  • 20
    Deligdisch L, de Resende Miranda CR, Wu HS, Gil J. Human papillomavirus-related cervical lesions in adolescents: a histologic and morphometric study. Gynecol Oncol 2003;89:529.
  • 21
    Schünemann H, Brozek J, Oxman A, editors. Grade handbook for grading the quality of evidence and the strength of recommendations; Version 3.2 [updated March 2009]. The GRADE Working Group, 2009.